Valuation: CURE Pharmaceutical Holding Corp.

Market Cap 23.68L 20.27L 18.91L 17.36L 32.61L 23Cr 33.26L 2.24Cr 87.47L 11Cr 88.9L 86.97L 38Cr P/E 2022
-0.43x
P/E 2023 -1.56x
Enterprise Value 1.06Cr 90.77L 84.69L 77.71L 1.46Cr 101.44Cr 1.49Cr 10Cr 3.92Cr 51Cr 3.98Cr 3.89Cr 168.31Cr EV / Sales 2022
3.94x
EV / Sales 2023 3.15x
Free-Float
98.82%
Yield 2022 *
-
Yield 2023 -
Manager TitleAgeSince
Chief Executive Officer 64 01/03/2025
Chief Tech/Sci/R&D Officer - 20/05/2019
Sales & Marketing - -
Director TitleAgeSince
Chairman 59 16/08/2022
Director/Board Member 72 01/01/2018
Director/Board Member 71 23/10/2020
Change 5-day change 1-year change 3-year change Capi.($)
+3.25%-2.07% - - 18.04T
-0.65%-3.17%-4.86%+52.03% 3,57300Cr
-0.70%-2.82%+11.51%+1,108.06% 42TCr
-0.44%-3.14%-9.22%+42.19% 8.64TCr
-0.42%-7.81%+81.03%+148.37% 8.35TCr
-0.83%-3.36%-33.80%-6.60% 7.62TCr
-1.56%-4.93%-34.41%+203.10% 7.18TCr
+1.31%-0.73%+5.02%+74.71% 4.49TCr
+0.39%+5.38%+5.02%-6.11% 4.43TCr
-0.67%+1.85%-18.10%-37.93% 3.44TCr
Average +0.12%-1.45%+0.24%+175.31% 49.25TCr
Weighted average by Cap. +0.47%-3.05%-2.66%+153.65%

Financials

2022 2023
Net sales 48.96L 41.92L 39.11L 35.89L 67.44L 47Cr 68.76L 4.64Cr 1.81Cr 23Cr 1.84Cr 1.8Cr 78Cr 43.47L 37.22L 34.73L 31.86L 59.88L 42Cr 61.05L 4.12Cr 1.61Cr 21Cr 1.63Cr 1.6Cr 69Cr
Net income -2.55Cr -2.18Cr -2.04Cr -1.87Cr -3.51Cr -244.08Cr -3.58Cr -24Cr -9.42Cr -122.32Cr -9.58Cr -9.37Cr -404.97Cr -34.44L -29.49L -27.51L -25.25L -47.44L -33Cr -48.37L -3.26Cr -1.27Cr -17Cr -1.29Cr -1.27Cr -55Cr
Net Debt 71.18L 60.94L 56.86L 52.18L 98.04L 68Cr 99.97L 6.75Cr 2.63Cr 34Cr 2.67Cr 2.61Cr 113Cr 82.34L 70.5L 65.78L 60.36L 1.13Cr 79Cr 1.16Cr 7.8Cr 3.04Cr 39Cr 3.09Cr 3.02Cr 130.72Cr
Logo CURE Pharmaceutical Holding Corp.
Avenir Wellness Solutions, Inc. is a platform technology company. The Company develops proprietary wellness, nutraceutical, and topical delivery systems. The Company is focused on the development of nutraceutical formulation and delivery technologies in novel dosage forms to improve wellness. Its wholly owned subsidiary, The Sera Labs, Inc. (Sera Labs), is engaged the development, production and sale of the Company’s wellness and beauty products. Sera Labs creates products that use science-backed, proprietary oral and topical formulations. The Company sells over 25 products under the brand names Seratopical, Seratopical Revolution SeraLabs, and Nutri-Stri. Sera Labs products are sold direct-to-consumer via online Website orders, including opt-in subscribe and save option, and also online and in-store at national drug, mass retailers, grocery chains and convenience stores and on Amazon.com.
Employees
-